Literature DB >> 7752185

Substituted (1,2-diarylethyl)amide acyl-CoA:cholesterol acyltransferase inhibitors: effect of polar groups on in vitro and in vivo activity.

J W Clader1, J G Berger, R E Burrier, H R Davis, M Domalski, S Dugar, T P Kogan, B Salisbury, W Vaccaro.   

Abstract

Substituted (1,2-diarylethyl)amides have been prepared and evaluated for their ability to inhibit microsomal acyl-CoA:cholesterol acyltransferase activity in vitro and to lower hepatic cholesteryl ester content in vivo in a cholesterol-fed hamster. Simple unsubstituted (diarylethyl)amides were potent inhibitors in vitro but showed poor activity in vivo. Introduction of polar groups at specific locations on the diarylethylamine moiety decreased in vitro activity but increased in vivo activity. Both effects were highly structure dependent, suggesting specific interactions which were mediating activity in each model. Optimization of these opposing effects led to compounds which were potent in both models.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7752185     DOI: 10.1021/jm00010a004

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  2 in total

1.  Design and synthesis of type-III mimetics of ShK toxin.

Authors:  Jonathan B Baell; Andrew J Harvey; Raymond S Norton
Journal:  J Comput Aided Mol Des       Date:  2002-04       Impact factor: 3.686

2.  AM-251 and SR144528 are acyl CoA:cholesterol acyltransferase inhibitors.

Authors:  Douglas Thewke; Natalie Freeman-Anderson; Theresa Pickle; Courtney Netherland; Courtney Chilton
Journal:  Biochem Biophys Res Commun       Date:  2009-02-11       Impact factor: 3.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.